This option might be particularly useful for patients suffering from MSPC and FKLC when they start developing skin lesions as a consequence of NLRP1 activation. The gene discussed is NLRP1; the disease is corneal intraepithelial dyskeratosis-palmoplantar hyperkeratosis-laryngeal dyskeratosis syndrome.